Hereditary Breast and Ovarian Cancer: Which Patients Are at High Risk?
Detecting hereditary cancer and providing genetic counseling can help prevent a new primary cancer and may also help to protect family members from developing cancer.
Metastatic Melanoma: Timely Approval of Yervoy
After a long fight with melanoma, the Roman Catholic parish priest Father Arthur Humphrey was able to receive the immunotherapeutic agent Yervoy, which greatly improved his prognosis.
Essential Components of Survivorship Care
At the 2012 NCCN annual meeting, a panel of oncology nurses discussed the essential components of healthcare for survivors, challenges survivors face, and survivorship program models.
Challenges With Managing Oral Cancer Treatments
Although oral treatments have revolutionized cancer care, their use presents challenges to both patients and providers.
Challenges and Breakthroughs in Cancer Pain Management
Cancer pain management has greatly improved with advances in oral and intravenous medication. However, several challenges still exist in administration.
Managing Dermatologic Toxicities Associated With Targeted Therapies
Many targeted therapies are associated with dermatologic side effects; the monitoring and treating of these side effects should be done on an individual patient basis.
Genetic Assessment of Breast and Ovarian Cancer Risk
Understanding the genetic basis of breast and ovarian cancers is essential to providing patients with effective preventive and/or management strategies that can improve outcomes.
National Comprehensive Cancer Network: Beyond the Treatment Guidelines
Each year at its annual meeting, the National Comprehensive Cancer Network presents updates to its Clinical Practice Guidelines in Oncology.
Olanzapine Significantly Reduces CINV in Patients Receiving MEC
Reimagining Frailty Screenings in Head and Neck Cancer
Screening for Pain and Depression is Not Enough in Cancer Care
Niraparib-Based Triplet Therapy Offers OS Advantage in BRCA1/2+ mCRPC
2 Clarke Drive Cranbury, NJ 08512